DBD vs DAVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 17, 2026
DBD
36.5
AI Score
VS
DAVE Wins
DAVE
41.0
AI Score
Investment Advisor Scores
DAVE
41score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | DBD | DAVE | Winner |
|---|---|---|---|
| Revenue | 1.82B | 329.21M | DBD |
| Net Income | 20.50M | 64.62M | DAVE |
| Net Margin | 1.1% | 19.6% | DAVE |
| ROE | 2.1% | 31.1% | DAVE |
| ROA | 0.5% | 11.3% | DAVE |
| Total Assets | 3.74B | 570.78M | DBD |
| Current Ratio | 1.27 | 4.22 | DAVE |
Relative Price Performance (Last 90 Days)
DBD 1M: +5.9%
· 3M: -21.6%
DAVE 1M: +6.6%
· 3M: -7.8%
Current Technical Phase
DBD
NeutralHold
Mixed signals - no dominant trend phase, RSI 60
DAVE
NeutralHold
Mixed signals - no dominant trend phase, RSI 58
Fundamentals Snapshot
| Metric | DBD | DAVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.7 | 16.9 |
| Trailing P/E | 22.4 | 23.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.3% |
| Gross Margin | 0.3% | 0.7% |
| Operating Margin | 0.1% | 0.3% |
| EPS | 3.03 | 15.51 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, DAVE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.